Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

Mrinal M. Patnaik, MBBS, Emnet A Wassie, MD, Eric Padron, MD, Francesco Onida, MD, Raphael Itzykson, Terra L Lasho, PhD, Olivier Kosmider, MD PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett Ketterling, MD, Rami S Komrokji, MD, Ayalew Tefferi, MD, Eric Solary

Blood (2014) 124 (21): 4633.

https://doi.org/10.1182/blood.V124.21.4633.4633

Published: 2014

Journal Articles

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

Ayalew Tefferi, MD, Terra L Lasho, PhD, Alexander Tischer, PhD, Emnet A Wassie, MD, Christy Finke, BS, Alem A Belachew, Rhett Ketterling, MD, Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD

Blood (2014) 124 (21): 3166.

https://doi.org/10.1182/blood.V124.21.3166.3166

Published: 2014

Journal Articles

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

Emnet A Wassie, MD, Christy Finke, BS, Naseema Gangat, MD, Terra L Lasho, PhD, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Ketterling Rhett, Ayalew Tefferi, MD

Blood (2014) 124 (21): 403.

https://doi.org/10.1182/blood.V124.21.403.403

Published: 2014

Journal Articles

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Emnet A Wassie, MD, Raphael Itzykson, Terra L Lasho, PhD, Olivier Kosmider, MD PhD, Christy Finke, BS, Curtis A. Hanson, MD, Rhett Ketterling, MD, Eric Solary, Ayalew Tefferi, MD, Mrinal M. Patnaik, MBBS

Blood (2014) 124 (21): 412.

https://doi.org/10.1182/blood.V124.21.412.412

Published: 2014

Journal Articles

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Ayalew Tefferi, MD, Emnet A Wassie, MD, Kebede Begna, MD, Christy Finke, BS, Alem A Belachew, Naseema Gangat, MD, Terra L Lasho, PhD, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD

Blood (2014) 124 (21): 631.

https://doi.org/10.1182/blood.V124.21.631.631

Published: 2014

Journal Articles

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Mrinal M. Patnaik, MBBS, Emnet A Wassie, MD, Terra L Lasho, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD, Ayalew Tefferi, MD

Blood (2014) 124 (21): 1932.

https://doi.org/10.1182/blood.V124.21.1932.1932

Published: 2014

Journal Articles

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson, Christy Finke, Emnet A. Wassie, Lisa Pieri, Naseema Gangat, Rajmonda Fjerza, Alem A. Belachew, Terra L. Lasho, Rhett P. Ketterling, Curtis A. Hanson, Alessandro Rambaldi, Guido Finazzi, Juergen Thiele, Tiziano Barbui, Animesh Pardanani, Alessandro M. Vannucchi

Blood (2014) 124 (16): 2507–2513.

https://doi.org/10.1182/blood-2014-05-579136

Published: 2014

Includes: Supplemental data

Journal Articles

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

Ayalew Tefferi, Terra L. Lasho, Alexander Tischer, Emnet A. Wassie, Christy M. Finke, Alem A. Belachew, Rhett P. Ketterling, Curtis A. Hanson, Animesh D. Pardanani

Blood (2014) 124 (15): 2465–2466.

https://doi.org/10.1182/blood-2014-07-588426

Published: 2014

Includes: Supplemental data

Journal Articles

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2 V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Ayalew Tefferi, MD, Christy Finke, BS, Terra L Lasho, MT, (ASCP), Emnet A Wassie, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD

Blood (2013) 122 (21): 4060.

https://doi.org/10.1182/blood.V122.21.4060.4060

Published: 2013

Journal Articles

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

Ayalew Tefferi, MD, Paola Guglielmelli, MD, Terra L Lasho, MT, (ASCP), Christy Finke, BS, Emnet A Wassie, MD, Ryan A Knudson, Rhett P Ketterling, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Alessandro M Vannucchi, MD

Blood (2013) 122 (21): 1587.

https://doi.org/10.1182/blood.V122.21.1587.1587

Published: 2013

NARROW

Chronic Myelomonocytic Leukemia in Young Patients: Molecular and Cytogenetic Predictors of Survival and Treatment Outcome

The Prognostic Advantage of Calreticulin Mutations in Myelofibrosis Might be Confined to Type 1 or “type 1-like” Calreticulin Variants

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

Molecular and Prognostic Correlates of Cytogenetic Abnormalities in Chronic Myelomonocytic Leukemia: A Mayo Clinic-French Consortium Study

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Blast Transformation in Chronic Myelomonocytic Leukemia: Risk Factors and Outcome

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

The prognostic advantage of calreticulin mutations in myelofibrosis might be confined to type 1 or type 1-like CALR variants

U2AF1 mutations In Primary Myelofibrosis Cluster With Normal Karyotype and JAK2 V617F and Are Strongly Associated With Anemia and Thrombocytopenia

Normal Karyotype Primary Myelofibrosis (NK-PMF): Clinical and Molecular Prognostication In 690 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only